Back to Market返回行情

GMED Globus Medical, Inc.

USHealthcare
$78.11+1.92%ClosedMarket Cap: $10.53B

As of 2026-07-10 16:00

Why GMED matters now

Globus Medical, Inc. (GMED) is a US stock in Healthcare. The latest InvestLog snapshot shows $78.11 with +1.92% on the session and $10.53B in market capitalization; recent performance reads 1-month -0.88% and YTD -9.25%.

The latest financial table shown here is Q1 2026, with revenue of $759.9M, net income of $124.3M, and EPS of $0.90. Investors can compare that operating picture with valuation signals such as P/E 22.74 and FCF yield 5.6%.

The latest indexable market news headline is "Here's Why Globus Medical (GMED) is a Strong Momentum Stock" from Zacks Investment Research.

Additional event context on this page matters because analyst consensus is Buy with a median target of $111.00; recent insider activity includes Davidar David D filing M-Exempt. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

22.74

PEG

0.05

P/B

2.27

P/S

3.45

EV/EBITDA

11.64

DCF Value

$39.71

FCF Yield

5.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

67.9%

Operating Margin

17.6%

Net Margin

18.9%

ROE

13.0%

ROA

10.8%

ROIC

9.7%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$759.9M$124.3M$0.90
Q4 2025$826.4M$140.6M$1.01
FY 2025$2.94B$537.9M$3.92
Q3 2025$769.0M$119.0M$0.88

Analyst Ratings

Consensus

Buy

Target (Consensus)

$109.50

Target (Median)

$111.00

Target Range

$100.00 - $117.00

Strong Buy: 3Buy: 6Hold: 4Sell: 0Strong Sell: 0
Piper SandlerOverweight
2026-06-15
NeedhamBuy
2026-05-08
RBC CapitalOutperform
2026-05-08
Wells FargoOverweight
2026-05-08
Wells FargoOverweight
2026-02-26

Trading Activity

Insider Trades

Davidar David Ddirector
Sell2026-06-09
Davidar David Ddirector
Sell2026-06-09
Davidar David Ddirector
Sell2026-06-09
RHOADS ANN Ddirector
Sell2026-06-08
RHOADS ANN Ddirector
Sell2026-06-08

Latest News

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

0.95

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.